David E Messenger
Overview
Explore the profile of David E Messenger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Messenger D, Rajaretnam N, Slade D
Colorectal Dis
. 2024 Jun;
26(8):1617-1631.
PMID: 38937910
Aim: Incisional herniation (IH) is a frequent complication following midline abdominal closure with significant associated morbidity. Randomized controlled trials have demonstrated that the small bites technique (SBT) and prophylactic mesh...
2.
Granger S, Preece R, Thomas M, Dixon S, Chambers A, Messenger D
Colorectal Dis
. 2023 Aug;
25(9):1771-1782.
PMID: 37553121
Aim: Proximal and distal colorectal cancers (CRCs) exhibit different clinical, molecular and biological patterns. The aim of this study was to determine temporal trends in the age-standardized incidence rates (ASIRs)...
3.
Orchard P, Preece R, Thomas M, Dixon S, Wong N, Chambers A, et al.
BJS Open
. 2022 Aug;
6(4).
PMID: 36029031
Aims: Recent data suggest that the incidence of malignant appendiceal tumours is increasing. This study aimed to determine temporal trends in the incidence of malignant appendiceal tumours within England and...
4.
Sari A, Cyr D, Brar A, Messenger D, Driman D, Shivji S, et al.
Am J Surg Pathol
. 2021 Aug;
46(2):200-212.
PMID: 34411028
Venous invasion (VI) is a powerful yet underreported prognostic factor in colorectal cancer (CRC). Its detection can be improved with an elastin stain. We evaluated the impact of routine elastin...
5.
Maccabe T, Parwaiz I, Longman R, Thomas M, Messenger D
Colorectal Dis
. 2020 Nov;
23(3):689-697.
PMID: 33140913
Aim: There is a paucity of data on outcomes from local excision (LE) of early anal squamous cell carcinomas (ASCCs). This study aimed to assess survival outcomes according to tumour...
6.
7.
Rogers L, Bleetman D, Messenger D, Joshi N, Wood L, Rasburn N, et al.
J Thorac Cardiovasc Surg
. 2018 Jan;
155(4):1843-1852.
PMID: 29352586
Objective: The adoption of Enhanced Recovery After Surgery programs in thoracic surgery is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery...
8.
Macefield R, Reeves B, Milne T, Nicholson A, Blencowe N, Calvert M, et al.
J Infect Prev
. 2017 Oct;
18(4):170-179.
PMID: 28989524
Background: Surgical site infections (SSIs) are the third most common hospital-associated infection and can lead to significant patient morbidity and healthcare costs. Identification of SSIs is key to surveillance and...
9.
Koelzer V, Assarzadegan N, Dawson H, Mitrovic B, Grin A, Messenger D, et al.
J Pathol Clin Res
. 2017 Aug;
3(3):171-178.
PMID: 28770101
Tumour budding in colorectal cancer is an important prognostic factor. A recent consensus conference elaborated recommendations and key issues for future studies, among those the use of pan-cytokeratin stains, especially...
10.
Forse C, Rahimi M, Diamandis E, Assarzadegan N, Dawson H, Grin A, et al.
Exp Mol Pathol
. 2017 Jul;
103(1):94-100.
PMID: 28716573
Tumor budding is a well-established adverse prognostic factor in colorectal carcinoma (CRC). It may represent a form of epithelial-to-mesenchymal transition (EMT), although the underlying mechanisms remain unclear. High-temperature requirement A3...